Skip to main content
Contact Us
Subscribe
E-Edition
56°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organogenesis Holdings Inc
(NQ:
ORGO
)
4.050
+0.030 (+0.75%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organogenesis Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday
November 13, 2024
Via
Benzinga
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript
November 12, 2024
ORGO earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 15, 2024
Via
Benzinga
Organogenesis (ORGO) Q2 2024 Earnings Call Transcript
August 09, 2024
ORGO earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Organogenesis Hldgs Q4 Earnings
February 29, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
A Preview Of Organogenesis Hldgs's Earnings
February 28, 2024
Via
Benzinga
ORGO Stock Earnings: Organogenesis Hldgs Beats Revenue for Q2 2024
August 08, 2024
ORGO stock results show that Organogenesis Hldgs beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Spotlight: Healthcare and Tech VTAK, ORGO, CDIO, LAZR, VLCN
May 13, 2024
Via
AB Newswire
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 10, 2024
Via
Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
ORGO Stock Earnings: Organogenesis Hldgs Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
ORGO stock results show that Organogenesis Hldgs beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
May 09, 2024
ORGO earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 25, 2024
Via
Benzinga
Why Organogenesis Holding Stock Plummeted by 18% Today
March 01, 2024
A double miss put the wound care specialist's shares on the sick list.
Via
The Motley Fool
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript
February 29, 2024
ORGO earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 15, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
January 01, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 27, 2023
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per...
Via
Benzinga
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
December 27, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Organogenesis Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 06, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
November 10, 2023
Via
Benzinga
Organogenesis (ORGO) Q3 2023 Earnings Call Transcript
November 09, 2023
ORGO earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Why Shares of Organogenesis Holdings Are Up Thursday
September 28, 2023
The company said it learned that its products will again be covered by three Medicare Administrative Contractors.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.